Literature DB >> 25884698

Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women.

Peng Duan1, Zhi-Ming Wang2, Jiang Liu3, Li-Na Wang4, Zhi Yang5, Ping Tu6.   

Abstract

BACKGROUND: Age at menarche (AAM) and age at natural menopause (AANM) have been shown intimately associated with woman's health later in life. Previous studies have indicated that AAM and AANM are highly heritable. RANKL/RANK/OPG signaling pathway is essential for mammary gland development, which is also found associated with post-menopausal and hormone-related diseases. The aim of this study was to evaluate associations between the polymorphisms in the TNFSF11, TNFRSF11A and TNFRSF11B genes in the RANKL/RANK/OPG pathway with AAM and AANM in Chinese women.
METHODS: Post-menopausal Chinese women (n = 845) aged from 42 to 89 years were recruited in the study. Information about AAM and AANM were obtained through questionnaires and the genomic DNA was isolated from peripheral blood from the participants. Total 21 tagging single nucleotide polymorphisms (SNPs) of TNFSF11, TNFRSF11A and TNFRSF11B were genotyped.
RESULTS: Three SNPs of TNFRSF11A (rs4500848, rs6567270 and rs1805034) showed significant association with AAM (P < 0.01, P = 0.02 and P = 0.01, respectively), and one SNP (rs9962159) was significantly associated with AANM (P = 0.03). Haplotypes TC and AT (rs6567270-rs1805034) of TNFRSF11A were found to be significantly associated with AAM (P = 0.01 and P = 0.02, respectively), and haplotypes GC and AC (rs9962159-rs4603673) of TNFRSF11A showed significant association with AANM (P = 0.03 and P < 0.01, respectively). No significant association between TNFSF11 or TNFRSF11B gene with AAM or AANM was found.
CONCLUSIONS: The present study suggests that TNFRSF11A but not TNFSF11 and TNFRSF11B genetic polymorphisms are associated with AAM and AANM in Chinese women. The findings provide evidence that genetic variations in RANKL/RANK/OPG pathway may be associated with the onset and cessation of the menstruation cycle.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25884698      PMCID: PMC4397679          DOI: 10.1186/s12905-015-0192-3

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


Background

Age at menarche (AAM) and age at natural menopause (AANM) have been shown intimately associated with woman’s health later in life. Women with early menarche have high risks of breast cancer [1], ovarian cancer [2], type 2 diabetes [3] or metabolic syndrome [4], whereas late menarche can increase the risk of osteoporosis [5]. On the other hand, early AANM is associated with increased risk of cardiovascular diseases [6] and osteoporosis [7]. Recent data have shown that AAM and AANM were associated with all-cause mortality [8]. However, the factors that affect AAM and AANM are not entirely clear. AAM and AANM are complex traits which are influenced by both genetic and environmental factors and their interactions [9]. Twin and familial studies have indicated that AAM and AANM are highly heritable, ranging from 45% to 74% for AAM [10,11] and from 49% to 87% for AANM [12,13]. Genes involved in hormone biosynthesis and metabolic pathways were found to be associated with AAM and AANM [14,15], however, no specific genes have been identified yet. The receptor activator of nuclear factor-kappa B ligand (RANKL), its receptor RANK and the decoy receptor osteoprotegerin (OPG) belong to the tumor necrosis factor superfamily and they are encoded by genes TNFSF11, TNFRSF11A and TNFRSF11B, respectively. RANKL/RANK/OPG signaling pathway plays important roles in bone modeling and remodeling [16], cell death and proliferation, inflammation, and immunity [17,18]. RANKL/RANK/OPG pathway is also found associated with post-menopausal and hormone-related diseases, such as osteoporosis [19] and reproductive cancer [20]. Furthermore, RANKL is found to be essential for mammary gland development in mice by promoting proliferation and maintaining survival of mammary epithelial cells [21]. Mammary gland changes are one of the hallmarks during menarche and menopause [22,23]. Therefore, RANKL/RANK/OPG pathway may involve in modulating the onset and cessation of the menstrual cycle. The present study investigated the associations of single nucleotide polymorphisms and haplotypes in TNFSF11, TNFRSF11A and TNFRSF11B genes in RANKL/RANK/OPG pathway with AAM and AANM in Chinese females.

Methods

Participants

A total 1026 post-menopausal women from ten community centers in Nanchang from December 2011 to December 2012 were enrolled in the study. All the participants were from Han Chinese ethnic group. Age at interview, AAM, AANM, detailed medical history, birth history (number of live delivery), and abortion information (number of abortions) were obtained through a self-designed questionnaire, all the information collected in the study was self-reported. AAM was defined as the age at the first menstrual period. AANM was defined as one year without menstruation after the age at the last menstrual period. For each participant, height (cm) and weight (kg) were measured. The body mass index (BMI) was calculated as weight/height2. All of the participants were subjected to blood counts, liver and kidney function tests, fasting plasma glucose tests. Subjects included in the study had normal blood counts, normal liver and kidney functions and blood glucose levels. Subjects were excluded from the study if they suffered from diseases and surgeries that could affect menstruation, such as severe chronic diseases, rheumatic diseases (e.g. systemic lupus erythematosus, rheumatoid arthritis), severe endocrine and metabolic diseases (e.g. diabetes, hyperparathyroidism, pituitary or adrenal diseases), malabsorption diseases (e.g. chronic diarrhea, anorexia nervosa), cancer, and uterine or ovarian resection. Participants who had taken glucocorticosteroid or sex hormone within the past 3 months were also excluded. Finally, 845 subjects were included in the study. The study was approved by the Ethics Committee of The Third Hospital of Nanchang. Written informed consent was obtained from every participant.

TagSNP selection

Tagging SNPs of the three genes were selected from the software program Haploview version 4.2 [24] (http://www.broad.mit.edu/mpg/haploview/) with minor allele frequencies (MAF) > 10% in the Chinese Han population in HapMap (http://www.hapmap.org/), and the pairwise linkage disequilibrium (LD) was greater than a threshold of r2 (r2 = 0.8). In addition to, SNPs reported in previous studies or potentially functional SNPs in three candidate genes were forced into the SNP selection process. Finally, a total of 21 SNPs were selected in three genes (9 in TNFRSF11A gene, 6 in TNFSF11 gene, and 6 in TNFRSF11B gene). Of these, 18 SNPs are located in the introns of the three genes, one in 5′-UTR, two in the exonic region. All of these SNPs were authenticated using the NCBI (http://www.ncbi.nlm.nih.gov/SNP/) and HapMap databases.

Genotyping

Approximately 5 mL of venous blood was collected from all of the participants after a minimum of 10 h fasting and stored in tubes containing 100 μL of 10% ethylene diaminetetraacetic acid (EDTA). Genomic DNA was extracted from whole blood samples using the QIAamp DNA Mini Kit (Qiagen Inc., Hilden, Germany). DNA samples concentration and quality were detected spectrophotometrically at 260/280 nm and stored at −80°C until analysed. Genotyping was performed using the high-throughput Sequenom genotyping platform (MassARRAY MALDI-TOF MS system, Sequenom Inc., San Diego, CA). For quality control, 5% of the samples were repeatedly genotyped, and the results were found to be 100% concordant.

Statistical analyses

Genotype frequencies and concordance of the SNPs were analyzed for the Hardy-Weinberg equilibrium (HWE) using the χ2 test. Data were expressed as mean ± standard deviation. The stepwise multiple regression analysis was used to analyze the relationships between the SNPs and AAM and AANM, subsequently, each SNP with different genotype was analyzed independently using one-way univariate analysis of variance (ANOVA), BMI, age at interview, number of deliveries and abortions were considered as covariates and were adjusted during analysis. Bonferroni correction was used to adjust the P values for multiple comparisons. The statistical analyses were performed using SPSS version 13.0 for Windows (SPSS Inc., Chicago, IL, USA). The linkage disequilibrium structure and allele frequencies were examined using Haploview 4.2 software [24]. The significance of each haplotype within the defined blocks was analyzed by PLINK software [25] (http://pngu.mgh.harvard.edu/~purcell/plink/). All analyses were two-tailed, and P -value < 0.05 was considered statistically significant.

Results

Characteristics of the study participants

The basic characteristics of the 845 participants aged from 42 to 89 years were shown in Table 1. The mean age at interview was 60.88 ± 8.72 years, the mean AAM was 14.97 ± 2.00 years and AANM was 48.77 ± 4.16 years. No statistically significant association was observed between AAM and AANM (P = 0.15).
Table 1

Characteristics of the 845 participants

Characteristics Average 95% CI
Age (years) 60.88 ± 8.7260.30-61.47
Age at menarche (years) 14.97 ± 2.0014.83-15.10
Age at menopause (years) 48.77 ± 4.1648.49-49.05
Height (cm) 154.18 ± 5.97153.78-154.58
Weight (kg) 58.21 ± 8.7357.62-58.80
BMI (kg/m 2 ) 24.46 ± 3.2024.25-24.68
Number of deliveries 2.14 ± 1.322.05-2.23
Number of spontaneous abortions 0.13 ± 0.440.10-0.16
Number of induced abortions 1.21 ± 1.271.13-1.30

The data are presented as the means ± standard deviation. BMI, body mass index. CI, confidence interval.

Characteristics of the 845 participants The data are presented as the means ± standard deviation. BMI, body mass index. CI, confidence interval.

SNP genotyping and linkage disequilibrium

The basic characteristics of the SNPs are listed in Table 2. All study SNPs had a minor allele frequency of at least 0.1 and were in agreement with Hardy-Weinberg equilibrium (P > 0.05). Linkage disequilibrium between alleles at polymorphic loci was shown in Figure 1. Four haplotype blocks and seventeen of the most common haplotypes (frequency > 5%) were further analyzed for the association of haplotype with AAM and AANM.
Table 2

Associations for the SNPs of and genes with AAM and AANM

Gene SNP Allele Function HWE MAF AAM AANM
Beta P P -Bonf Beta P P -Bonf
TNFRSF11B rs1485286 C/T Intron 0.4237T = 0.4060.06970.491.000.24280.251.00
TNFRSF11B rs11573869 A/G Intron 0.8783G = 0.165−0.05290.691.000.11090.681.00
TNFRSF11B rs3102728 T/C Intron 0.2913C = 0.1380.07260.611.00−0.23520.431.00
TNFRSF11B rs11573819 G/A Intron 0.9402A = 0.1570.05010.711.00−0.17090.541.00
TNFRSF11B rs2073618 C/G Asn by Lys 0.5148G = 0.258−0.00650.951.000.26870.251.00
TNFRSF11B rs2073617 A/G UTR-5 0.7887G = 0.382−0.11370.261.000.17410.411.00
TNFSF11 rs9525641 T/C Intron 0.1546C = 0.4720.08100.421.00−0.06560.751.00
TNFSF11 rs2277439 A/G Intron 0.5905G = 0.295−0.06110.561.000.24300.271.00
TNFSF11 rs2324851 G/A Intron 0.6728A = 0.294−0.06990.511.000.23510.291.00
TNFSF11 rs2875459 C/T Intron 0.8542T = 0.220−0.10360.381.00−0.01890.941.00
TNFSF11 rs2200287 G/A Intron 0.8891A = 0.220−0.08980.441.00−0.02150.941.00
TNFSF11 rs9533166 T/C Intron 0.5125C = 0.131−0.16940.231.00−0.21540.471.00
TNFRSF11A rs9962159 A/G Intron 0.4172G = 0.4350.13380.171.00−0.44340.030.57
TNFRSF11A rs4603673 C/G Intron 0.7190G = 0.162−0.13630.311.00−0.25510.361.00
TNFRSF11A rs7239261 C/A Intron 0.2342A = 0.239−0.16560.141.000.31230.181.00
TNFRSF11A rs4500848 C/T Intron 0.7267T = 0.262−0.3395<0.010.04−0.03780.871.00
TNFRSF11A rs6567270 T/A Intron 0.1116A = 0.4080.22650.020.390.11970.551.00
TNFRSF11A rs1805034 T/C Ala by Val 0.3758C = 0.288−0.27900.010.220.00690.981.00
TNFRSF11A rs4303637 C/T Intron 0.9818C = 0.4710.16180.101.000.07010.731.00
TNFRSF11A rs4941131 T/C Intron 0.8166C = 0.3300.04370.671.00−0.18920.381.00
TNFRSF11A rs9646629 G/C Intron 0.2416C = 0.4600.14610.141.00−0.22560.281.00

HWE, P values for Hardy-Weinberg equilibrium. MAF, minor allele frequency. Beta, the regression coefficient. P-Bonf, P-value by Bonferroni correction. AAM, age at menarche. AANM, age at natural menopause.

Figure 1

Linkage disequilibrium (LD) patterns for TNFSF11, TNFRSF11A and TNFRSF11B genes. LD plots with r 2 values were generated by Haploview software. R2 values are indicated by the degree of darkness, increasing from white to black. The D’ values multiplied by 100 are shown as numbers in the diamonds. There are one in TNFSF11 (block 1), two blocks in TNFRSF11A (block 2 and block 3), and one in TNFRSF11B (block 4), respectively.

Associations for the SNPs of and genes with AAM and AANM HWE, P values for Hardy-Weinberg equilibrium. MAF, minor allele frequency. Beta, the regression coefficient. P-Bonf, P-value by Bonferroni correction. AAM, age at menarche. AANM, age at natural menopause. Linkage disequilibrium (LD) patterns for TNFSF11, TNFRSF11A and TNFRSF11B genes. LD plots with r 2 values were generated by Haploview software. R2 values are indicated by the degree of darkness, increasing from white to black. The D’ values multiplied by 100 are shown as numbers in the diamonds. There are one in TNFSF11 (block 1), two blocks in TNFRSF11A (block 2 and block 3), and one in TNFRSF11B (block 4), respectively.

Association analyses of the SNP and haplotypes with AAM and AANM

Three SNPs in TNFRSF11A, i.e. rs4500848, rs6567270 and rs1805034, showed significant association with AAM (P  < 0.01, P = 0.02 and P = 0.01, respectively), whereas only rs9962159 in TNFRSF11A was significantly associated with AANM (P = 0.03) (Table 2). After correction of age at interview, BMI, number of deliveries and abortions, the associations between those SNPs and AAM or AANM were found significant. After the Bonferroni correction, the rs4500848 was still significantly associated with AAM (P = 0.04), however, the associations between the others SNPs with AAM or AANM were no longer statistically significant (Table 2). Individuals with the T/T genotype of SNP rs4500848 had an earlier onset of menarche by 0.59 years than did those with the C/C genotype. Likewise, women with the G/G genotype of SNP rs9962159 had an earlier menopause by 0.79 years than those with the A/A genotype (Table 3).
Table 3

Significant associations for the single SNPs of and genes with AAM and AANM

Genotype n AAM Genotype n AAM
rs4500848 rs1805034
C/C 47115.16 ± 1.95 C/C 6414.53 ± 2.17
C/T 31314.76 ± 2.07 C/T 35814.86 ± 2.04
T/T 6114.57 ± 1.85 T/T 42315.12 ± 1.93
P-value <0.01 P-value 0.04
Genotype n AAM Genotype n AANM
rs6567270 rs9962159
A/A 15215.35 ± 2.07 G/G 16648.45 ± 4.18
A/T 38514.92 ± 2.02 G/A 40348.56 ± 4.23
T/T 30814.84 ± 1.91 A/A 27649.26 ± 4.00
P-value 0.03 P-value 0.05
Significant associations for the single SNPs of and genes with AAM and AANM Two haplotypes (TC and AT) of block rs6567270-rs1805034 of TNFRSF11A were found significantly associated with AAM (P = 0.01 and P = 0.02, respectively) (Table 4). Haplotypes GC and AC of block rs9962159-rs4603673 of TNFRSF11A were significantly associated with AANM (P = 0.03 and P  < 0.01, respectively). Haplotype TAGCGT of block rs9525641-rs2277439-rs2324851-rs2875459-rs2200287-rs9533166 of TNFSF11 showed marginally significant association with AAM (P = 0.06). Notably, all the significantly associated SNPs and haplotypes were observed in TNFRSF11A. SNPs and haplotypes in TNFSF11 and TNFRSF11B genes did not show significant association with either AAM or AANM.
Table 4

The associations of haplotypes of and genes with AAM and AANM

Gene Haplotype Frequency AAM AANM
Beta P Beta P
TNFSF11: rs9525641-rs2277439-rs2324851-rs2875459-rs2200287-rs9533166
TAGTAC 0.131−0.16860.24−0.21710.46
TAGTAT 0.0880.01480.930.23920.50
TGACGT 0.292−0.07370.490.19580.38
CAGCGT 0.4690.07730.44−0.10070.63
TAGCGT 0.0170.78540.06−1.33000.09
TNFRSF11A: rs9962159-rs4603673
AG 0.161−0.14550.28−0.24320.38
GC 0.4340.12940.18−0.43830.03
AC 0.405−0.05780.550.5747<0.01
TNFRSF11A : rs6567270-rs1805034
TC 0.288−0.27870.010.00690.98
AT 0.4080.22630.020.11970.55
TT 0.305−0.01130.91−0.14080.51
TNFRSF11B : rs1485286-rs11573869-rs3102728-rs11573819-rs2073618
TATGG 0.2500.03110.780.27910.24
CATAC 0.1550.07700.57−0.18080.52
CACGC 0.1390.07260.61−0.23520.43
CGTGC 0.164−0.04070.760.10670.70
TATGC 0.1540.09550.480.04100.88
CATGC 0.130−0.20410.17−0.18280.56

The analyses were performed under an additive model adjusted for age at interview and BMI. Beta, regression coefficient.

The associations of haplotypes of and genes with AAM and AANM The analyses were performed under an additive model adjusted for age at interview and BMI. Beta, regression coefficient.

Discussion

According to the previous studies, there was a direct relationship between AAM and AANM, women with earlier menarche had earlier menopause in Poland [26]. However, other studies had reported no association between AAM and AANM [27]. In this tudy, no statistically significant association was observed between AAM and AANM. The present study revealed that three SNPs (rs4500848, rs6567270 and rs1805034) and two haplotypes of TNFRSF11A showed significant association with AAM in Chinese women. These findings are in line to a previous report by Pan et al. [28], the authors found five SNPs (rs7239261, rs8094884, rs3826620, rs8089829, and rs9956850) and seven haplotypes of TNFRSF11A significantly associated with AAM in Chinese women. Thus, polymorphisms in TNFRSF11A are highly associated with AAM in Chinese women. In contrast to TNFRSF11A, SNPs of TNFSF11 did not show association with AAM in our study. Noticeably, two SNPs (rs9525641 and rs2200287) of TNFSF11 displayed a strong association with AAM in white women [29], but no significant association was observed between the two SNPs and AAM in our study. The inconsistency between the results of the present study and the other [29] may due to the different ethnic populations used, different sample sizes and statistical approaches. The inconsistent results were also observed in the association of TNFSF11 gene polymorphisms and AANM. In the present study, no significant association between polymorphisms of TNFSF11 and AANM was found in Chinese women, however, such relationship was reported in white women, two SNPs (rs346578 and rs9525641) of TNFSF11 showed association with AANM [29]. Regardless of the discrepancy in TNFSF11, we and the others [29] both found a strong association between polymorphisms of TNFRSF11A and AANM. The associations between polymorphisms of TNFRSF11A with AAM and AANM found in the present study can be explained by its possible roles in mammary gland development and menstruation. First, TNFRSF11A belongs to RANKL/RANK/OPG signaling pathway. RANKL plays an important role in mammary gland development, indicating its potential role in regulating or responding to sex hormone fluctuation and subsequently influencing menstrual cycles. Studies have shown that gonadotropin-releasing hormone (GnRH) can modulate RANKL expression in breast cancer cells [30], and expressions of RANK and RANKL in different cell lines are controlled by estrogen [31], follicle-stimulating hormone [32], and dehydroepiandrosterone [33]. Estrogen is also found to regulate gene expression and ratio of the RANKL/OPG [34]. Second, RANKL signaling pathway can stimulate ductal side-branching and alveologenesis in the mammary gland in mouse [35]. RANKL can be induced in mammary epithelium and can regulate the proliferation of cells [36]. Therefore, RANK signaling pathway may influence onset of puberty and menstrual cycle by regulating mammary gland development. Third, genome-wide association (GWA) studies have identified some novel genetic loci associated with AAM and AANM [37,38]. Gene set enrichment pathway analyses using the GWA dataset found that nuclear factor-kappa B (NF-κB) signaling pathway may be associated with timing of menopause [39]. Recent studies have revealed that NF-κB pathway plays an important role in mammary ductal morphogenesis [40], and ovarian cell function in animals [41]. It was well established that the RANKL/RANK/OPG pathway can activate NF-κB and its downstream players [42]. Thus, genes (e.g. TNFRSF11A) in the RANKL/RANK/OPG pathway may have role in the onset and cessation of the menstruation cycle. The present study has some limitations. First, beside genetic other factors can influence timing of menarche and menopause, e.g. environment and socioeconomic status. We studied only the relationship between genetic variations and AAM and AANM. Furthermore, gene-environment interactions may also play a role in causing variation in the AAM and AANM. Second, The data of AAM and AANM were collected through retrospective self-report, which may cause recall bias. The participants in the study were aged from 42 to 89 years, with long interval periods, which might potentially incur recall error. It is reported that the accuracy of long-term recall of AAM and AANM varied from 70% to 84% [43,44]. In fact, it was found that some participants could not remember the exact age at the first menstrual period, and those subjects were excluded from the study. Large-scale studies are needed to confirm current findings, and the precise mechanisms underlying the observed associations in our study remain to be determined.

Conclusions

The present study, for the first time, demonstrated that TNFRSF11A but not TNFSF11 and TNFRSF11B genetic polymorphisms are associated with AAM and AANM in Chinese women. The findings provide evidence that genetic variations in RANKL/RANK/OPG pathway may be associated with the onset and cessation of the menstruation cycle.
  44 in total

1.  The role of genetic factors in age at natural menopause.

Authors:  J P de Bruin; H Bovenhuis; P A van Noord; P L Pearson; J A van Arendonk; E R te Velde; W W Kuurman; M Dorland
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

2.  Validity and reproducibility of self-reported age at menopause in women participating in the DOM-project.

Authors:  I den Tonkelaar
Journal:  Maturitas       Date:  1997-06       Impact factor: 4.342

3.  IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development.

Authors:  Y Cao; G Bonizzi; T N Seagroves; F R Greten; R Johnson; E V Schmidt; M Karin
Journal:  Cell       Date:  2001-12-14       Impact factor: 41.582

Review 4.  RANKL-RANK signaling in osteoclastogenesis and bone disease.

Authors:  Teiji Wada; Tomoki Nakashima; Nishina Hiroshi; Josef M Penninger
Journal:  Trends Mol Med       Date:  2005-12-13       Impact factor: 11.951

5.  Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study.

Authors:  Rebecca Ritte; Annekatrin Lukanova; Anne Tjønneland; Anja Olsen; Kim Overvad; Sylvie Mesrine; Guy Fagherazzi; Laure Dossus; Birgit Teucher; Karen Steindorf; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sara Grioni; Amalia Mattiello; Rosario Tumino; Carlotta Sacerdote; José Ramón Quirós; Genevieve Buckland; Esther Molina-Montes; María-Dolores Chirlaque; Eva Ardanaz; Pilar Amiano; Bas Bueno-de-Mesquita; Franzel van Duijnhoven; Carla H van Gils; Petra Hm Peeters; Nick Wareham; Kay-Tee Khaw; Timothy J Key; Ruth C Travis; Sanda Krum-Hansen; Inger Torhild Gram; Eiliv Lund; Malin Sund; Anne Andersson; Isabelle Romieu; Sabina Rinaldi; Valerie McCormack; Elio Riboli; Rudolf Kaaks
Journal:  Int J Cancer       Date:  2012-11-14       Impact factor: 7.396

Review 6.  Determinants of menarche.

Authors:  Olga Karapanou; Anastasios Papadimitriou
Journal:  Reprod Biol Endocrinol       Date:  2010-09-30       Impact factor: 5.211

7.  Expression of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression.

Authors:  Antje Schubert; Hiltrud Schulz; Günter Emons; Carsten Gründker
Journal:  Gynecol Endocrinol       Date:  2008-06       Impact factor: 2.260

8.  The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.

Authors:  S Bord; D C Ireland; S R Beavan; J E Compston
Journal:  Bone       Date:  2003-02       Impact factor: 4.398

9.  Genome-wide association studies identify loci associated with age at menarche and age at natural menopause.

Authors:  Chunyan He; Peter Kraft; Constance Chen; Julie E Buring; Guillaume Paré; Susan E Hankinson; Stephen J Chanock; Paul M Ridker; David J Hunter; Daniel I Chasman
Journal:  Nat Genet       Date:  2009-05-17       Impact factor: 38.330

10.  Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.

Authors:  Denis Lane; Isabelle Matte; Claude Laplante; Perrine Garde-Granger; Claudine Rancourt; Alain Piché
Journal:  J Ovarian Res       Date:  2013-11-23       Impact factor: 4.234

View more
  4 in total

Review 1.  Genetics of pubertal timing.

Authors:  Jia Zhu; Temitope O Kusa; Yee-Ming Chan
Journal:  Curr Opin Pediatr       Date:  2018-08       Impact factor: 2.856

Review 2.  Women's reproductive span: a systematic scoping review.

Authors:  A F Nabhan; G Mburu; F Elshafeey; R Magdi; M Kamel; M Elshebiny; Y G Abuelnaga; M Ghonim; M H Abdelhamid; Mo Ghonim; P Eid; A Morsy; M Nasser; N Abdelwahab; F Elhayatmy; A A Hussein; N Elgabaly; E Sawires; Y Tarkhan; Y Doas; N Farrag; A Amir; M F Gobran; M Maged; M Abdulhady; Y Sherif; M Dyab; J Kiarie
Journal:  Hum Reprod Open       Date:  2022-02-11

3.  FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis.

Authors:  Hua Qian; Xiaoyue Guan; Zhuan Bian
Journal:  Mol Med Rep       Date:  2016-08-09       Impact factor: 2.952

4.  Polymorphisms within the RANK and RANKL Encoding Genes in Patients with Rheumatoid Arthritis: Association with Disease Progression and Effectiveness of the Biological Treatment.

Authors:  Joanna Wielińska; Katarzyna Kolossa; Jerzy Świerkot; Marta Dratwa; Milena Iwaszko; Bartosz Bugaj; Barbara Wysoczańska; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2020-08-19       Impact factor: 4.291

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.